Newsfeeds - Spark Newswire

1 minute read

Redhill Biopharma: Q2 Earnings Insights

Today, 2:45 PM

Shares of Redhill Biopharma (NASDAQ:RDHL) rose 11.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 250.00% year over year to ($0.06), which beat the estimate of ($0.12).

RDHL

1 minute read

Redhill Biopharma Q2 EPS $(0.06) Beats $(0.12) Estimate, Sales $21.50M Miss $25.02M Estimate

By Benzinga Newsdesk

Today, 2:45 PM

Redhill Biopharma (NASDAQ:RDHL) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.12) by 50 percent. This is a 250 percent decrease over earnings of $0.04 per share from the

RDHL

2 minute read

News

RedHill Biopharma’s Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant

By Benzinga Newsdesk

Today, 2:45 PM

RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced preliminary results of a new preclinical study showing strong inhibition

RDHL

4 minute read

Earnings Scheduled For August 26, 2021

By Benzinga Insights

Today, 2:45 PM

Companies Reporting Before The Bell • Gambling.com Gr (NASDAQ:GAMB) is likely to report quarterly earnings at $0.07 per share on revenue of $10.38 million.

AFYA

2 minute read

Earnings

A Preview Of Redhill Biopharma’s Earnings

By Benzinga Insights

Today, 2:45 PM

Redhill Biopharma (NASDAQ:RDHL) will be releasing its next round of earnings this Thursday, August 26. For all of the relevant information, here is your guide for Thursday's Q2 earnings announcement.

RDHL

1 minute read

RedHill Biopharma Announces Two New US Patents Covering Opaganib For Ebola Virus And RHB-104 For Crohn’s

By Bill Haddad

Today, 2:45 PM

RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued two

RDHL

1 minute read

Legal
News

CORRECTION: RedHill Biopharma US Patent & Trademark Office Abstract Shows Co. Granted Patent For ‘Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine’

By Benzinga Newsdesk

Today, 2:45 PM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FP[…]637&f=G&l=50&d=PTXT&p=133&S1=20210817&OS=20210817&RS=20210817

RDHL

1 minute read

Legal
News

RedHill Biopharma US Patent & Trademark Office Abstract Shows Co. Granted Patent For ‘Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine’

By Benzinga Newsdesk

Today, 2:45 PM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FP[…]637&f=G&l=50&d=PTXT&p=133&S1=20210817&OS=20210817&RS=20210817

RDHL

1 minute read

RedHill Biopharma Ltd. Granted US Patent ‘Compositions for treating ebola virus infection’

By Bill Haddad

Today, 2:45 PM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6638&f=G&l=50&d=PTXT&p=133&S1=20210817&OS=20210817&RS=20210817

RDHL